Dickhoff C - Search Results

1

Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review.

Ulas EB, Dickhoff C, Schneiders FL, Senan S, Bahce I. Ulas EB, et al. Among authors: dickhoff c. ESMO Open. 2021 Oct;6(5):100244. doi: 10.1016/j.esmoop.2021.100244. Epub 2021 Aug 31. ESMO Open. 2021. PMID: 34479033 Free PMC article. Review.

2

Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancer.

Vos CG, Dahele M, Dickhoff C, Senan S, Thunnissen E, Hartemink KJ. Vos CG, et al. Among authors: dickhoff c. Acta Oncol. 2013 Apr;52(3):676-8. doi: 10.3109/0284186X.2012.718794. Epub 2012 Oct 25. Acta Oncol. 2013. PMID: 23098694 No abstract available.

3

Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC.

Bahce I, Vos CG, Dickhoff C, Hartemink KJ, Dahele M, Smit EF, Boellaard R, Hoekstra OS, Thunnissen E. Bahce I, et al. Among authors: dickhoff c. Lung Cancer. 2014 Aug;85(2):205-12. doi: 10.1016/j.lungcan.2014.04.010. Epub 2014 Apr 29. Lung Cancer. 2014. PMID: 24854401

4

Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.

Dickhoff C, Hartemink KJ, van de Ven PM, van Reij EJ, Senan S, Paul MA, Smit EF, Dahele M. Dickhoff C, et al. Lung Cancer. 2014 Aug;85(2):218-23. doi: 10.1016/j.lungcan.2014.06.005. Epub 2014 Jun 16. Lung Cancer. 2014. PMID: 24976333

5

Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.

Dickhoff C, Dahele M, de Langen AJ, Paul MA, Smit EF, Senan S, Hartemink KJ, Damhuis RA. Dickhoff C, et al. J Thorac Oncol. 2016 Apr;11(4):566-72. doi: 10.1016/j.jtho.2016.01.002. Epub 2016 Jan 8. J Thorac Oncol. 2016. PMID: 26773741 Free article.

6

Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer.

Dickhoff C, Dahele M, Paul MA, van de Ven PM, de Langen AJ, Senan S, Smit EF, Hartemink KJ. Dickhoff C, et al. Lung Cancer. 2016 Apr;94:108-13. doi: 10.1016/j.lungcan.2016.02.005. Epub 2016 Feb 11. Lung Cancer. 2016. PMID: 26973215

7

Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?

Dickhoff C, Hartemink KJ, Kooij J, van de Ven PM, Paul MA, Smit EF, Dahele M. Dickhoff C, et al. Ann Oncol. 2017 Jan 1;28(1):185. doi: 10.1093/annonc/mdw449. Ann Oncol. 2017. PMID: 27687305 Free article. No abstract available.

8

Radical-Intent Treatment of Lung Cancer after Prior Thoracic Radiotherapy.

Dickhoff C, Senan S, Dahele M. Dickhoff C, et al. J Thorac Oncol. 2017 Mar;12(3):e26-e27. doi: 10.1016/j.jtho.2016.12.009. J Thorac Oncol. 2017. PMID: 28215727 Free article. No abstract available.

9

Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung Cancer.

Dickhoff C, Dahele M, Hashemi SM, Senan S, Smit EF, Hartemink KJ, Paul MA. Dickhoff C, et al. Ann Thorac Surg. 2017 Aug;104(2):436-442. doi: 10.1016/j.athoracsur.2017.02.055. Epub 2017 May 26. Ann Thorac Surg. 2017. PMID: 28552373

10

Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry.

Dickhoff C, Dahele M, Smit EF, Paul MA, Senan S, Hartemink KJ, Damhuis RA. Dickhoff C, et al. Lung Cancer. 2017 Aug;110:14-18. doi: 10.1016/j.lungcan.2017.05.015. Epub 2017 May 18. Lung Cancer. 2017. PMID: 28676212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters